Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders

Anemia is a common feature of liver and bowel diseases. Although the main causes of anemia in these conditions are represented by gastrointestinal bleeding and iron deficiency, autoimmune hemolytic anemia should be considered in the differential diagnosis. Due to the epidemiological association, aut...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2021-01, Vol.10 (3), p.423
Main Authors: Bianco, Cristiana, Coluccio, Elena, Prati, Daniele, Valenti, Luca
Format: Article
Language:English
Subjects:
Anemia
Antibodies
Cholangitis
Clinical medicine
Crohn's disease
Hepatitis
Hypertension
Inflammation
Inflammatory bowel disease
Iron
Liver diseases
Liver transplants
Medical prognosis
Remission (Medicine)
Review
Steroids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c409t-8e586b669de8797f5d345eeb7adfee0cccbd94fe61e75bb13ef13688a3f83e9c3
cites cdi_FETCH-LOGICAL-c409t-8e586b669de8797f5d345eeb7adfee0cccbd94fe61e75bb13ef13688a3f83e9c3
container_end_page
container_issue 3
container_start_page 423
container_title Journal of clinical medicine
container_volume 10
creator Bianco, Cristiana
Coluccio, Elena
Prati, Daniele
Valenti, Luca
description Anemia is a common feature of liver and bowel diseases. Although the main causes of anemia in these conditions are represented by gastrointestinal bleeding and iron deficiency, autoimmune hemolytic anemia should be considered in the differential diagnosis. Due to the epidemiological association, autoimmune hemolytic anemia should particularly be suspected in patients affected by inflammatory and autoimmune diseases, such as autoimmune or acute viral hepatitis, primary biliary cholangitis, and inflammatory bowel disease. In the presence of biochemical indices of hemolysis, the direct antiglobulin test can detect the presence of warm or cold reacting antibodies, allowing for a prompt treatment. Drug-induced, immune-mediated hemolytic anemia should be ruled out. On the other hand, the choice of treatment should consider possible adverse events related to the underlying conditions. Given the adverse impact of anemia on clinical outcomes, maintaining a high clinical suspicion to reach a prompt diagnosis is the key to establishing an adequate treatment.
doi_str_mv 10.3390/jcm10030423
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7865399</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2481640561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-8e586b669de8797f5d345eeb7adfee0cccbd94fe61e75bb13ef13688a3f83e9c3</originalsourceid><addsrcrecordid>eNpdkV1LHDEUhoO0qFivvJdAbwplbTLJ5OOmsPWzsNJe6HXIZM6sWSaJTWaU_feOusrWc5MDeXh4Dy9CR5ScMKbJj5ULlBBGeMV20H5FpJwRptinrX0PHZayItMoxSsqd9EeY1zrSpN91Jx5u4yp-IJtbPG1jXYJAeKAU4fn45B8CGMEfAUh9evBOzyPELzFPuK_dvATWfCjH-7wwj9AfpH8So_Q4zNfUm4hly_oc2f7Aoeb9wDdXpzfnF7NFn8uf5_OFzPHiR5mCmolGiF0C0pq2dUt4zVAI23bARDnXNNq3oGgIOumoQw6yoRSlnWKgXbsAP189d6PTYDWTdGy7c199sHmtUnWm_9_or8zy_RgpBI103oSfNsIcvo3QhlM8MVB39sIaSym4ooKTmpBJ_TrB3SVxhyn80wlOCWcSion6vsr5XIqJUP3HoYS81yf2apvoo-387-zb2WxJ6v8lys</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641041717</pqid></control><display><type>article</type><title>Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Bianco, Cristiana ; Coluccio, Elena ; Prati, Daniele ; Valenti, Luca</creator><creatorcontrib>Bianco, Cristiana ; Coluccio, Elena ; Prati, Daniele ; Valenti, Luca</creatorcontrib><description>Anemia is a common feature of liver and bowel diseases. Although the main causes of anemia in these conditions are represented by gastrointestinal bleeding and iron deficiency, autoimmune hemolytic anemia should be considered in the differential diagnosis. Due to the epidemiological association, autoimmune hemolytic anemia should particularly be suspected in patients affected by inflammatory and autoimmune diseases, such as autoimmune or acute viral hepatitis, primary biliary cholangitis, and inflammatory bowel disease. In the presence of biochemical indices of hemolysis, the direct antiglobulin test can detect the presence of warm or cold reacting antibodies, allowing for a prompt treatment. Drug-induced, immune-mediated hemolytic anemia should be ruled out. On the other hand, the choice of treatment should consider possible adverse events related to the underlying conditions. Given the adverse impact of anemia on clinical outcomes, maintaining a high clinical suspicion to reach a prompt diagnosis is the key to establishing an adequate treatment.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm10030423</identifier><identifier>PMID: 33499290</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Anemia ; Antibodies ; Cholangitis ; Clinical medicine ; Crohn's disease ; Hepatitis ; Hypertension ; Inflammation ; Inflammatory bowel disease ; Iron ; Liver diseases ; Liver transplants ; Medical prognosis ; Remission (Medicine) ; Review ; Steroids</subject><ispartof>Journal of clinical medicine, 2021-01, Vol.10 (3), p.423</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-8e586b669de8797f5d345eeb7adfee0cccbd94fe61e75bb13ef13688a3f83e9c3</citedby><cites>FETCH-LOGICAL-c409t-8e586b669de8797f5d345eeb7adfee0cccbd94fe61e75bb13ef13688a3f83e9c3</cites><orcidid>0000-0003-4611-6781 ; 0000-0001-8909-0345</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2641041717/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2641041717?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33499290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bianco, Cristiana</creatorcontrib><creatorcontrib>Coluccio, Elena</creatorcontrib><creatorcontrib>Prati, Daniele</creatorcontrib><creatorcontrib>Valenti, Luca</creatorcontrib><title>Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Anemia is a common feature of liver and bowel diseases. Although the main causes of anemia in these conditions are represented by gastrointestinal bleeding and iron deficiency, autoimmune hemolytic anemia should be considered in the differential diagnosis. Due to the epidemiological association, autoimmune hemolytic anemia should particularly be suspected in patients affected by inflammatory and autoimmune diseases, such as autoimmune or acute viral hepatitis, primary biliary cholangitis, and inflammatory bowel disease. In the presence of biochemical indices of hemolysis, the direct antiglobulin test can detect the presence of warm or cold reacting antibodies, allowing for a prompt treatment. Drug-induced, immune-mediated hemolytic anemia should be ruled out. On the other hand, the choice of treatment should consider possible adverse events related to the underlying conditions. Given the adverse impact of anemia on clinical outcomes, maintaining a high clinical suspicion to reach a prompt diagnosis is the key to establishing an adequate treatment.</description><subject>Anemia</subject><subject>Antibodies</subject><subject>Cholangitis</subject><subject>Clinical medicine</subject><subject>Crohn's disease</subject><subject>Hepatitis</subject><subject>Hypertension</subject><subject>Inflammation</subject><subject>Inflammatory bowel disease</subject><subject>Iron</subject><subject>Liver diseases</subject><subject>Liver transplants</subject><subject>Medical prognosis</subject><subject>Remission (Medicine)</subject><subject>Review</subject><subject>Steroids</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNpdkV1LHDEUhoO0qFivvJdAbwplbTLJ5OOmsPWzsNJe6HXIZM6sWSaJTWaU_feOusrWc5MDeXh4Dy9CR5ScMKbJj5ULlBBGeMV20H5FpJwRptinrX0PHZayItMoxSsqd9EeY1zrSpN91Jx5u4yp-IJtbPG1jXYJAeKAU4fn45B8CGMEfAUh9evBOzyPELzFPuK_dvATWfCjH-7wwj9AfpH8So_Q4zNfUm4hly_oc2f7Aoeb9wDdXpzfnF7NFn8uf5_OFzPHiR5mCmolGiF0C0pq2dUt4zVAI23bARDnXNNq3oGgIOumoQw6yoRSlnWKgXbsAP189d6PTYDWTdGy7c199sHmtUnWm_9_or8zy_RgpBI103oSfNsIcvo3QhlM8MVB39sIaSym4ooKTmpBJ_TrB3SVxhyn80wlOCWcSion6vsr5XIqJUP3HoYS81yf2apvoo-387-zb2WxJ6v8lys</recordid><startdate>20210122</startdate><enddate>20210122</enddate><creator>Bianco, Cristiana</creator><creator>Coluccio, Elena</creator><creator>Prati, Daniele</creator><creator>Valenti, Luca</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4611-6781</orcidid><orcidid>https://orcid.org/0000-0001-8909-0345</orcidid></search><sort><creationdate>20210122</creationdate><title>Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders</title><author>Bianco, Cristiana ; Coluccio, Elena ; Prati, Daniele ; Valenti, Luca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-8e586b669de8797f5d345eeb7adfee0cccbd94fe61e75bb13ef13688a3f83e9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anemia</topic><topic>Antibodies</topic><topic>Cholangitis</topic><topic>Clinical medicine</topic><topic>Crohn's disease</topic><topic>Hepatitis</topic><topic>Hypertension</topic><topic>Inflammation</topic><topic>Inflammatory bowel disease</topic><topic>Iron</topic><topic>Liver diseases</topic><topic>Liver transplants</topic><topic>Medical prognosis</topic><topic>Remission (Medicine)</topic><topic>Review</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bianco, Cristiana</creatorcontrib><creatorcontrib>Coluccio, Elena</creatorcontrib><creatorcontrib>Prati, Daniele</creatorcontrib><creatorcontrib>Valenti, Luca</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bianco, Cristiana</au><au>Coluccio, Elena</au><au>Prati, Daniele</au><au>Valenti, Luca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2021-01-22</date><risdate>2021</risdate><volume>10</volume><issue>3</issue><spage>423</spage><pages>423-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Anemia is a common feature of liver and bowel diseases. Although the main causes of anemia in these conditions are represented by gastrointestinal bleeding and iron deficiency, autoimmune hemolytic anemia should be considered in the differential diagnosis. Due to the epidemiological association, autoimmune hemolytic anemia should particularly be suspected in patients affected by inflammatory and autoimmune diseases, such as autoimmune or acute viral hepatitis, primary biliary cholangitis, and inflammatory bowel disease. In the presence of biochemical indices of hemolysis, the direct antiglobulin test can detect the presence of warm or cold reacting antibodies, allowing for a prompt treatment. Drug-induced, immune-mediated hemolytic anemia should be ruled out. On the other hand, the choice of treatment should consider possible adverse events related to the underlying conditions. Given the adverse impact of anemia on clinical outcomes, maintaining a high clinical suspicion to reach a prompt diagnosis is the key to establishing an adequate treatment.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33499290</pmid><doi>10.3390/jcm10030423</doi><orcidid>https://orcid.org/0000-0003-4611-6781</orcidid><orcidid>https://orcid.org/0000-0001-8909-0345</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2021-01, Vol.10 (3), p.423
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7865399
source Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database
subjects Anemia
Antibodies
Cholangitis
Clinical medicine
Crohn's disease
Hepatitis
Hypertension
Inflammation
Inflammatory bowel disease
Iron
Liver diseases
Liver transplants
Medical prognosis
Remission (Medicine)
Review
Steroids
title Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A29%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20Management%20of%20Autoimmune%20Hemolytic%20Anemia%20in%20Patients%20with%20Liver%20and%20Bowel%20Disorders&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Bianco,%20Cristiana&rft.date=2021-01-22&rft.volume=10&rft.issue=3&rft.spage=423&rft.pages=423-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm10030423&rft_dat=%3Cproquest_pubme%3E2481640561%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-8e586b669de8797f5d345eeb7adfee0cccbd94fe61e75bb13ef13688a3f83e9c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2641041717&rft_id=info:pmid/33499290&rfr_iscdi=true